Literature DB >> 20567539

Probiotic therapy for irritable bowel syndrome.

George Aragon1, Deborah B Graham, Marie Borum, David B Doman.   

Abstract

The etiology of irritable bowel syndrome (IBS) is thought to be multifactorial, with several factors (including alterations in gut motility, small-bowel bacterial overgrowth, microscopic inflammation, and visceral hypersensitivity) potentially playing a role. Recent studies have suggested that probiotics may be useful in the treatment of IBS. Although the exact mechanism for how probiotics may aid in the reduction of symptoms commonly found in IBS is unknown, the effects of probiotics on alterations in gut bacteria appear to play a part. This review focuses on recent studies examining the role of probiotics in the treatment of IBS.

Entities:  

Keywords:  Irritable bowel syndrome; probiotics; small-bowel bacterial overgrowth

Year:  2010        PMID: 20567539      PMCID: PMC2886445     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  43 in total

1.  Activation of the mucosal immune system in irritable bowel syndrome.

Authors:  Vinton S Chadwick; Wangxue Chen; Dairu Shu; Barbara Paulus; Peter Bethwaite; Andy Tie; Ian Wilson
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

Review 2.  An evidence-based position statement on the management of irritable bowel syndrome.

Authors:  Lawrence J Brandt; William D Chey; Amy E Foxx-Orenstein; Lawrence R Schiller; Philip S Schoenfeld; Brennan M Spiegel; Nicholas J Talley; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

3.  Evidence for two distinct perceptual alterations in irritable bowel syndrome.

Authors:  B D Naliboff; J Munakata; S Fullerton; R H Gracely; A Kodner; F Harraf; E A Mayer
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

4.  The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat.

Authors:  Lieve Desbonnet; Lillian Garrett; Gerard Clarke; John Bienenstock; Timothy G Dinan
Journal:  J Psychiatr Res       Date:  2008-05-05       Impact factor: 4.791

Review 5.  The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.

Authors:  Darren M Brenner; Matthew J Moeller; William D Chey; Philip S Schoenfeld
Journal:  Am J Gastroenterol       Date:  2009-03-10       Impact factor: 10.864

6.  Terminal ileal mucosal mast cells in irritable bowel syndrome.

Authors:  A P Weston; W L Biddle; P S Bhatia; P B Miner
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

7.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

8.  Altered rectal perception is a biological marker of patients with irritable bowel syndrome.

Authors:  H Mertz; B Naliboff; J Munakata; N Niazi; E A Mayer
Journal:  Gastroenterology       Date:  1995-07       Impact factor: 22.682

9.  Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

Authors:  D Guyonnet; O Chassany; P Ducrotte; C Picard; M Mouret; C-H Mercier; C Matuchansky
Journal:  Aliment Pharmacol Ther       Date:  2007-08-01       Impact factor: 8.171

10.  A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome.

Authors:  H J Kim; M Camilleri; S McKinzie; M B Lempke; D D Burton; G M Thomforde; A R Zinsmeister
Journal:  Aliment Pharmacol Ther       Date:  2003-04-01       Impact factor: 8.171

View more
  21 in total

1.  The potential influence of the microbiota and probiotics on women during long spaceflights.

Authors:  Camilla Urbaniak; Gregor Reid
Journal:  Womens Health (Lond)       Date:  2016-02-22

Review 2.  Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.

Authors:  Nathaniel Aviv Cohen; Nitsan Maharshak
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

3.  Potential probiotic Kluyveromyces marxianus B0399 modulates the immune response in Caco-2 cells and peripheral blood mononuclear cells and impacts the human gut microbiota in an in vitro colonic model system.

Authors:  Simone Maccaferri; Annett Klinder; Patrizia Brigidi; Piero Cavina; Adele Costabile
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

4.  Gut inflammation in chronic fatigue syndrome.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  Nutr Metab (Lond)       Date:  2010-10-12       Impact factor: 4.169

5.  Effect of composite yogurt enriched with acacia fiber and Bifidobacterium lactis.

Authors:  Yang Won Min; Sang Un Park; Yeon Sil Jang; Young-Ho Kim; Poong-Lyul Rhee; Seo Hyun Ko; Nami Joo; Sun Im Kim; Cheol-Hyun Kim; Dong Kyung Chang
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

6.  An Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.

Authors:  Lin Chang; Brian E Lacy; Brennan M R Spiegel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-09

7.  Brain-gut-microbe communication in health and disease.

Authors:  Sue Grenham; Gerard Clarke; John F Cryan; Timothy G Dinan
Journal:  Front Physiol       Date:  2011-12-07       Impact factor: 4.566

8.  Carbohydrate Elimination or Adaptation Diet for Symptoms of Intestinal Discomfort in IBD: Rationales for "Gibsons' Conundrum".

Authors:  Q Manyan Fung; Andrew Szilagyi
Journal:  Int J Inflam       Date:  2012-02-29

9.  Are probiotics effective in management of irritable bowel syndrome?

Authors:  Asieh Hosseini; Shekoufeh Nikfar; Mohammad Abdollahi
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

10.  The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial.

Authors:  Katsumi Murakami; Chizu Habukawa; Yukihiro Nobuta; Naohiko Moriguchi; Tsukasa Takemura
Journal:  Biopsychosoc Med       Date:  2012-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.